COVID-19 has changed the entire world. In Medlior’s latest blog post, we look at vaccine development and approval in Canada, answering questions about how the vaccines could be developed so quickly, and what contributed to Canada’s slow start in rolling them out....
The ISPOR 2021 annual conference was held last week. As usual, there were numerous insightful and thought-provoking sessions and workshops to attend, aimed at improving health economics and outcomes research (HEOR) research methods. Unsurprisingly, the COVID-19...
What is Synthetic Data? Synthetic data is the generation of realistic datasets that capture important relationships and information from real-world data. These datasets are created through random sampling models, such as Bayesian or neural networks, with the help of...
People who use drugs, particularly opioids, are a group that has been disproportionately impacted by the COVID-19 pandemic. Safe consumption sites and homeless shelters are supports often relied upon by people who use drugs. During the pandemic, these supports have...
Explore a list of all of Medlior's recent publications including recent Medlior evidence generation publications and recent Medlior RWE publications. Recent Medlior RWE publications Scory T, Chen G, Farris M, Shih YH, Pinto L, Cowling T. Lipid-lowering therapy...
Across the globe, the COVID-19 pandemic has negatively impacted healthcare delivery including: delays in elective or non-urgent surgeries and procedures, disruptions to cancer screening, and cessation of routine laboratory tests. In Canada, the Canadian Institute for...
The Canadian Survey on Disability (CSD) is a repeated cross-sectional survey of Canadians 15 years of age and older living with disability.1 Conducted by Statistics Canada, CSD participants are recruited from individuals who reported having a long-term health related...
Medlior was pleased to work with the Canadian Agency for Drugs and Technologies in Health (CADTH) to prepare a report on virus-neutralizing monoclonal antibodies for the treatment of SARS-CoV-2 infection, as part of CADTH’s Coronavirus Disease (COVID-19) evidence...
In January of 2020, we started the year with a passion for innovation and collaboration to produce impactful health outcomes research projects. We certainly could not have predicted the year that would follow, and while it was unprecedented, it also emphasized the...
